CoChat
Sign Up
Cited by 13Infectious Encephalopathies and EncephalitisViral Infections and Immunology ResearchHerpesvirus Infections and Treatments

Neurology of Acute Viral Infections

Open access
Krett, Jonathan D, Beckham, J David, Tyler, Kenneth L, Piquet, Amanda L, Chauhan, Lakshmi, Wallace, Carla J, Pastula, Daniel M, Kapadia, Ronak K·2022·The Neurohospitalist
DOI 10.1177/19418744221104778PMC PMC9485684
Open this paper in CoChat — free account

Abstract

As specialists in acute neurology, neurohospitalists are often called upon to diagnose and manage acute viral infections affecting the nervous system. In this broad review covering the neurology of several acute viral infections, our aim is to provide key diagnostic and therapeutic pearls of practical use to the busy neurohospitalist. We will review acute presentations, diagnosis, and treatment of human herpesviruses, arboviruses, enteroviruses, and some vaccine-preventable viruses. The neurological effects of coronaviruses, including COVID-19, are not covered in this review.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/19418744221104778

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HHV-6 can cause severe CNS disease, especially in immunocompromised hosts, but a positive HHV-6 finding may also result from subclinical reactivation of the latent virus or chromosomal integration and may not be relevant for the CNS infection.

    “Although HHV-6 can cause severe CNS disease, especially in immunocompromised hosts, a positive HHV-6 finding may also result from subclinical reactivation of the latent virus or chromosomal integration and may not be relevant for the CNS infection (26–29).”

    From Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel (2023) · cites this paper as [29]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 93

  1. [1]Hjalmarsson A Blomqvist P Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: Incidence, morbidity, and mortality. Clin Infect Dis. 2007; 45(7): 875- 880. doi: 10.1086/521262 17806053 · DOI
  2. [2]Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes. 2004; 11 Suppl 2(suppl 2): 57A- 64A. 15319091
  3. [3]Tunkel AR Glaser CA Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2008; 47(3): 303- 327. doi: 10.1086/589747 18582201 · DOI · Paper page
  4. [4]Bradshaw MJ Venkatesan A. Herpes simplex virus-1 encephalitis in adults: Pathophysiology, diagnosis, and management. Neurotherapeutics. 2016; 13(3): 493- 508. doi: 10.1007/s13311-016-0433-7 27106239 PMC4965403 · DOI
  5. [5]Raschilas F Wolff M Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis. 2002; 35(3): 254- 260. doi: 10.1086/341405 12115090 · DOI
  6. [6]Lakeman FD Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis. 1995; 171(4): 857- 863. doi: 10.1093/infdis/171.4.857 7706811 · DOI
  7. [7]DeBiasi RL Kleinschmidt-DeMasters BK Weinberg A Tyler KL. Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol. 2002; 25(suppl 1): S5- 11. doi: 10.1016/s1386-6532(02)00028-8 12091076 · DOI
  8. [8]Weil AA Glaser CA Amad Z Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. 2002; 34(8): 1154- 1157. doi: 10.1086/339550 11915008 · DOI
  9. [9]Bewersdorf JP Koedel U Patzig M, et al. Challenges in HSV encephalitis: Normocellular CSF, unremarkable CCT, and atypical MRI findings. Infect. 2019; 47(2): 267- 273. doi: 10.1007/s15010-018-1257-7 30506479 · DOI
  10. [10]Granerod J Davies NWS Mukonoweshuro W, et al. Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement. Clin Radiology. 2016; 71(10): 1050- 1058. doi: 10.1016/j.crad.2016.03.015 PMC5021199 27185323 · DOI
  11. [11]Tan IL McArthur JC Venkatesan A Nath A. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurol. 2012; 79(21): 2125- 2132. doi: 10.1212/WNL.0b013e3182752ceb PMC3511927 23136265 · DOI
  12. [12]Lai C-W Gragasin ME. Electroencephalography in herpes simplex encephalitis. J Clin Neurophysiol. 1988; 5(1): 87- 104. doi: 10.1097/00004691-198801000-00003 3150762 · DOI
  13. [13]Hughes PS Jackson AC. Delays in initiation of acyclovir therapy in herpes simplex encephalitis. Can J Neurol Sci. 2012; 39(5): 644- 648. doi: 10.1017/s0317167100015390 22931707 · DOI · Paper page
  14. [15]Armangue T Spatola M Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: A prospective observational study and retrospective analysis. Lancet Neurol. 2018; 17(9): 760- 772. doi: 10.1016/s1474-4422(18)30244-8 30049614 PMC6128696 · DOI
  15. [17]Landry ML Greenwold J Vikram HR. Herpes simplex type-2 meningitis: Presentation and lack of standardized therapy. Am J Med. 2009; 122(7): 688- 691. doi: 10.1016/j.amjmed.2009.02.017 19559173 · DOI
  16. [18]Miller S Mateen FJ Aksamit AJ Jr. Herpes simplex virus 2 meningitis: A retrospective cohort study. J NeuroVirol. 2013; 19(2): 166- 171. doi: 10.1007/s13365-013-0158-x 23494382 · DOI
  17. [19]Tedder DG Ashley R Tyler KL Levin MJ. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Annals of Internal Medicine. 1994; 121(5): 334- 338. doi: 10.7326/0003-4819-121-5-199409010-00004 8042822 · DOI
  18. [20]Shalabi M Whitley RJ. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006; 43(9): 1194- 1197. doi: 10.1086/508281 17029141 · DOI
  19. [21]Berger JR Houff S. Neurological complications of herpes simplex virus type 2 infection. Archives Neurol. 2008; 65(5): 596- 600. doi: 10.1001/archneur.65.5.596 18474734 · DOI
  20. [22]Franzen-Rohl E Tiveljung-Lindell A Grillner L Aurelius E. Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples. J Clin Microbiol. 2007; 45(8): 2516- 2520. doi: 10.1128/JCM.00141-07 17567785 PMC1951252 · DOI
  21. [23]Nagot N Ouédraogo A Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007; 356(8): 790- 799. doi: 10.1056/NEJMoa062607 17314338 · DOI
  22. [24]Hait AS Thomsen MM Larsen SM, et al. Whole-exome sequencing of patients with recurrent HSV-2 lymphocytic mollaret meningitis. J Infect Dis. 2020; 223: 1776- 1786. doi: 10.1093/infdis/jiaa589 32946550 · DOI
  23. [25]Goyal T Ali I. Recurrent herpes simplex virus 2 lymphocytic meningitis in patient with IgG subclass 2 deficiency. Emerg Infect Dis. 2020; 26(4): 748- 750. doi: 10.3201/eid2604.190406 32186491 PMC7101106 · DOI
  24. [27]Gilden D Nagel MA Cohrs RJ Mahalingam R. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep. 2013; 13(9): 374. doi: 10.1007/s11910-013-0374-z 23884722 PMC4051361 · DOI
  25. [28]Lewis GW. Zoster sine herpete. Bmj. 1958; 2(5093): 418- 421. doi: 10.1136/bmj.2.5093.418 13560886 PMC2026052 · DOI
  26. [29]Baldwin KJ Cummings CL. Herpesvirus infections of the nervous system. Continuum (Minneap Minn). 2018; 24(5): 1349- 1369. doi: 10.1212/CON.0000000000000661 30273243 · DOI · Paper page
  27. [30]Nagel MA. Forghani B Mahalingam R, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007; 68(13): 1069- 1073. doi: 10.1212/01.wnl.0000258549.13334.16 17287447 · DOI
  28. [31]Reiber H Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: Sensitive and specific detection of antibody synthesis in brain. Clinical Chemistry. 1991; 37(7): 1153- 1160. 1855284
  29. [32]Gilden D Cohrs RJ Mahalingam R Nagel MA. Varicella zoster virus vasculopathies: Diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009; 8(8): 731- 740. doi: 10.1016/S1474-4422(09)70134-6 19608099 PMC2814602 · DOI
  30. [33]Cheng H Chen D Peng X Wu P Jiang L Hu Y. Clinical characteristics of Epstein-Barr virus infection in the pediatric nervous system. BMC Infect Dis. 2020; 2520(1): 886. doi: 10.1186/s12879-020-05623-1 PMC7691062 33238935 · DOI
  31. [34]Kennedy PGE. An overview of viral infections of the nervous system in the immunosuppressed. Journal of Neurology. 2020; 268: 3026- 3030. doi: 10.1007/s00415-020-10265-z 33048220 PMC7552955 · DOI
  32. [37]De Paschale M Clerici P. Serological diagnosis of Epstein-Barr virus infection: Problems and solutions. World Journal of Virology. 2012; 1(1): 31- 43. doi: 10.5501/wjv.v1.i1.31 24175209 PMC3782265 · DOI
  33. [38]Guo Y Wang S Jiang B, et al. Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults. Neuropsychiatric Disease and Treatment. 2017; 13: 2085- 2092. doi: 10.2147/NDT.S135510 28831257 PMC5548266 · DOI
  34. [39]Cinque P Brytting M Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet (London, England). 1993; 342(8868): 398- 401. doi: 10.1016/0140-6736(93)92814-a 8101902 · DOI
  35. [40]Weinberg A Li S Palmer M Tyler KL. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Annals of Neurology. 2002; 52(5): 543- 548. doi: 10.1002/ana.10321 12402250 · DOI
  36. [41]Weinberg A Bloch KC Li S Tang YW Palmer M Tyler KL. Dual infections of the central nervous system with epstein‐barr virus. J Infect Dis. 2005; 191(2): 234- 237. doi: 10.1086/426402 15609233 · DOI
  37. [42]Liu Q-F Ling Y-W Fan Z-P, et al. Epstein-Barr virus (EBV) load in cerebrospinal fluid and peripheral blood of patients with EBV-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis. 2013; 15(4): 379- 392. doi: 10.1111/tid.12090 23692640 · DOI
  38. [43]Yager JE Magaret AS Kuntz SR, et al. Valganciclovir for the suppression of epstein-barr virus replication. The J Infect Dis. 2017; 216(2): 198- 202. doi: 10.1093/infdis/jix263 28838145 PMC5854009 · DOI
  39. [44]Pagano J Whitehurst C Andrei G. Antiviral drugs for EBV. Cancers. 2018; 10(6): 197.doi: 10.3390/cancers10060197 PMC6025560 29899236 · DOI
  40. [45]Wagner JN Leibetseder A Troescher A Panholzer J von Oertzen TJ. Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review. J Neurol. 2022; 269(2): 712- 724. doi: 10.1007/s00415-021-10494-w 33675421 PMC8782811 · DOI
  41. [46]Cannon MJ Schmid DS Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Medical Virology. 2010; 20(4): 202- 213. doi: 10.1002/rmv.655 20564615 · DOI · Paper page
  42. [47]Gaur P Ffrench-Constant S Kachramanoglou C Lyall H Jan W. Is it not time for international guidelines to combat congenital cytomegalovirus infection? A review of central nervous system manifestations. Clinical Radiology. 2020; 75(8): e7- 644. doi: 10.1016/j.crad.2020.02.009 32216960 · DOI
  43. [48]Ceballos ME Rodriguez I Sandoval P Abbot E Labarca J. Cytomegalovirus encephalitis in the post-HAART era. AIDS. 2018; 32(4): 533- 535. doi: 10.1097/QAD.0000000000001732 29381563 · DOI
  44. [49]Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes. 2004; 11(suppl 2): 95A- 104A. 15319096
  45. [50]Jabs DA Belfort R Jr. Bodaghi B, et al. Classification criteria for cytomegalovirus retinitis. Am J Ophthalmol. 2021; 228: 245- 254. doi: 10.1016/j.ajo.2021.03.051 33845015 PMC8594755 · DOI
  46. [51]Palma P Costa A Duro R, et al. Mononeuritis multiplex: An uncommon neurological manifestation of cytomegalovirus reactivation in an HIV-infected patient. BMC Infectious Diseases. 2018; 1218(1): 554. doi: 10.1186/s12879-018-3501-2 PMC6233374 30419847 · DOI
  47. [52]Renard T Daumas-Duport B Auffray-Calvier E Bourcier R Desal H. Cytomegalovirus encephalitis: Undescribed diffusion-weighted imaging characteristics. Original aspects of cases extracted from a retrospective study, and from literature review. J Neuroradiol. 2016; 43(6): 371- 377. doi: 10.1016/j.neurad.2016.03.004 27137084 · DOI
  48. [53]Cinque P Cleator GM Weber T, et al. Diagnosis and clinical management of neurological disorders caused by Cytomegalovirus in aids patients. J Neurovirol. 1998; 4(1): 120- 132. doi: 10.3109/13550289809113490 9531020 · DOI
  49. [54]Zerr DM Meier AS Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005; 352(8): 768- 776. doi: 10.1056/NEJMoa042207 15728809 · DOI · Paper page
  50. [55]Le Guennec L Mokhtari K Chauvet D, et al. Human Herpesvirus 6 (HHV-6) necrotizing encephalitis, a rare condition in immunocompromised patients: The importance of brain biopsy associated with HHV-6 testing. J Neurol Sci. 2017; 377: 112- 115. doi: 10.1016/j.jns.2017.04.003 28477677 · DOI
  51. [56]Seeley WW Marty FM Holmes TM, et al. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6. Neurol. 2007; 69(2): 156- 165. doi: 10.1212/01.wnl.0000265591.10200.d7 17620548 · DOI
  52. [57]Ward KN Leong HN Thiruchelvam AD Atkinson CE Clark DA. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol. 2007; 45(4): 1298- 1304. doi: 10.1128/JCM.02115-06 17229866 PMC1865851 · DOI · Paper page
  53. [59]Ward KN Hill JA Hubacek P, et al. Guidelines from the 2017 European conference on infections in leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation. Haematologica. 2019; 104(11): 2155- 2163. doi: 10.3324/haematol.2019.223073 31467131 PMC6821622 · DOI
  54. [60]Petersen LR Brault AC Nasci RS. West Nile virus: Review of the literature. JAMA. 2013; 310(3): 308- 315. doi: 10.1001/jama.2013.8042 23860989 PMC4563989 · DOI
  55. [61]Sejvar JJ. West nile virus: An historical overview. Ochsner J. 2003; 5(3): 6- 10. PMC3111838 21765761
  56. [62]Davis LE DeBiasi R Goade DE, et al. West Nile virus neuroinvasive disease. Annals Neurol. 2006; 60(3): 286- 300. doi: 10.1002/ana.20959 16983682 · DOI
  57. [63]Lenka A Kamat A Mittal SO. Spectrum of movement disorders in patients with neuroinvasive west nile virus infection. Mov Disord Clin Pract. 2019; 6(6): 426- 433. doi: 10.1002/mdc3.12806 31392241 PMC6660229 · DOI
  58. [64]Yu A Ferenczi E Moussa K Eliott D Matiello M. Clinical spectrum of west nile virus neuroinvasive disease. Neurohospitalist. 2020; 10(1): 43- 47. doi: 10.1177/1941874419868636 31839864 PMC6900655 · DOI
  59. [65]Jean CM Honarmand S Louie JK Glaser CA. Risk factors for west nile virus neuroinvasive disease, California, 2005. Em Infect Dis. 2007; 13(12): 1918- 1920. doi: 10.3201/eid1312.061265 PMC2876738 18258047 · DOI
  60. [66]Vanichanan J Salazar L Wootton SH, et al. Use of testing for west nile virus and other arboviruses. Em Infect Dis. 2016; 22(9). doi: 10.3201/eid2209.152050 PMC4994361 27537988 · DOI
  61. [67]Owens M Choe L Rivera JE Avila JD. West Nile virus neuroinvasive disease associated with rituximab therapy. J NeuroVirol. 2020; 26(4): 611- 614. doi: 10.1007/s13365-020-00854-z 32472356 · DOI
  62. [68]Levi ME Quan D Ho JT Kleinschmidt-Demasters BK Tyler KL Grazia TJ. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplantation. 2010; 24(2): 223- 228. doi: 10.1111/j.1399-0012.2009.01044.x PMC2873850 19659514 · DOI
  63. [69]Tardei G Ruta S Chitu V Rossi C Tsai TF Cernescu C. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection. J Clin Microbiol. 2000; 38(6): 2232- 2239. doi: 10.1128/JCM.38.6.2232-2239.2000 10834982 PMC86770 · DOI
  64. [70]Tyler KL. Current developments in understanding of West Nile virus central nervous system disease. Curr Opin Neurol. 2014; 27(3): 342- 348. doi: 10.1097/WCO.0000000000000088 24722324 PMC4050660 · DOI
  65. [71]Kapoor H Signs K Somsel P Downes FP Clark PA Massey JP. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol. 2004; 31(4): 289- 291. doi: 10.1016/j.jcv.2004.05.017 15494271 · DOI
  66. [72]Tyler KL Pape J Goody RJ Corkill M Kleinschmidt-DeMasters BK. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurol. 2006; 66(3): 361- 365. doi: 10.1212/01.wnl.0000195890.70898.1f 16382032 · DOI
  67. [73]Ali M Safriel Y Sohi J Llave A Weathers S. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol. 2005; 26(2): 289- 297. 15709126 PMC7974109
  68. [74]Gnann JW Jr. Agrawal A Hart J, et al. Lack of efficacy of high-titered immunoglobulin in patients with west nile virus central nervous system disease. Em Infect Dis. 2019; 25(11): 2064- 2073. doi: 10.3201/eid2511.190537 PMC6810207 31625835 · DOI
  69. [75]Hughes JM Wilson ME Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis. 2007; 44(12): 1617- 1624. doi: 10.1086/518281 17516407 · DOI
  70. [76]Piantadosi A Kanjilal S. Diagnostic approach for arboviral infections in the United States. J Clin Microbiol. 2020; 58(12). doi: 10.1128/JCM.01926-19 PMC7685875 32938736 · DOI
  71. [77]Schultz JS Sparks H Beckham JD. Arboviral central nervous system infections. Curr Opin Neurol. 2021; 34(3): 264- 271. doi: 10.1097/QCO.0000000000000729 33899755 · DOI
  72. [78]Chen B-S Lee H-C Lee K-M Gong Y-N Shih S-R. Enterovirus and Encephalitis. Front Microbiol. 2020; 11: 261. doi: 10.3389/fmicb.2020.00261 32153545 PMC7044131 · DOI
  73. [79]Dunn JJ. Enteroviruses and parechoviruses. Microbiol Spec. 2016; 4(3). doi: 10.1128/microbiolspec.DMIH2-0006-2015 27337462 · DOI
  74. [80]Ayscue P Van Haren K Sheriff H, et al. Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014. MMWR. 2014; 63(40): 903- 906. 25299608 PMC4584614
  75. [81]Murphy OC Messacar K Benson L, et al. Acute flaccid myelitis: Cause, diagnosis, and management. Lancet. 2021; 397(10271): 334- 346.doi: 10.1016/S0140-6736(20)32723-9 33357469 PMC7909727 · DOI
  76. [82]Pastula DM Aliabadi N Haynes AK, et al. Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014. MMWR. 2014; 63(40): 901- 902. 25299607 PMC4584613
  77. [84]Valcour V Haman A Cornes S, et al. A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia. Nat Clin Pract Neurol. 2008; 4(7): 399- 403. doi: 10.1038/ncpneuro0804 18477991 PMC2637149 · DOI
  78. [85]Tellez R Lastinger AM Hogg JP. Chronic enteroviral meningoencephalitis in a patient on rituximab for the treatment of psoriatic arthritis: A case report and brief literature review. IDCases. 2019; 17: e00558. doi: 10.1016/j.idcr.2019.e00558 31193253 PMC6522838 · DOI
  79. [86]Bitnun A Yeh EA. Acute flaccid paralysis and enteroviral infections. Curr Opin Neurol. 2018; 20(9): 34. doi: 10.1007/s11908-018-0641-x 29959591 · DOI
  80. [87]Sejvar JJ Lopez AS Cortese MM, et al. Acute flaccid myelitis in the United States, August-December 2014: Results of Nationwide Surveillance. Clin Infect Dis. 2016; 63(6): 737- 745. doi: 10.1093/cid/ciw372 27318332 PMC5709818 · DOI
  81. [88]Wagner JN Leibetseder A Troescher A Panholzer J von Oertzen TJ. Characteristics and therapy of enteroviral encephalitis: Case report and systematic literature review. Intern J Infect Dis. 2021; 113: 93- 102. doi: 10.1016/j.ijid.2021.10.002 34628025 · DOI
  82. [89]Brew BJ Garber JY. Neurologic sequelae of primary HIV infection. Handb Clin Neurol. 2018; 152: 65- 74. doi: 10.1016/B978-0-444-63849-6.00006-2 29604985 · DOI
  83. [90]Hellmuth J Fletcher JLK Valcour V, et al. Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurol. 2016; 87(2): 148- 154. doi: 10.1212/WNL.0000000000002837 PMC4940060 27287217 · DOI
  84. [91]Tambussi G Gori A Capiluppi B, et al. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis. 2000; 30(6): 962- 965. doi: 10.1086/313810 10880317 · DOI
  85. [92]Valcour V Chalermchai T Sailasuta N, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012; 206(2): 275- 282. doi: 10.1093/infdis/jis326 22551810 PMC3490695 · DOI
  86. [93]Wendel KA McArthur JC. Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication. Clin Infect Dis. 2003; 37(8): 1107- 1111. doi: 10.1086/378300 14523776 · DOI
  87. [94]Lescure F-X Moulignier A Savatovsky J, et al. CD8 encephalitis in HIV-infected patients receiving cART: A treatable entity. Clin Infect Dis. 2013; 57(1): 101- 108. doi: 10.1093/cid/cit175 23515205 · DOI
  88. [95]Lucas SB Wong KT Nightingale S Miller RF. HIV-Associated CD8 Encephalitis: A UK Case Series and Review of Histopathologically Confirmed Cases. Frontiers Neurol. 2021; 12: 628296. doi: 10.3389/fneur.2021.628296 PMC8047670 33868143 · DOI
  89. [96]Fooks AR Cliquet F Finke S, et al. Rabies. Nature Reviews Disease Primers. 2017; 3: 17091. doi: 10.1038/nrdp.2017.91 29188797 · DOI
  90. [97]Prevention. Recovery of a patient from clinical rabies-Wisconsin, 2004. MMWR. 2004; 53(50): 1171- 1173. 15614231
  91. [99]Buchanan R Bonthius DJ. Measles virus and associated central nervous system sequelae. Seminars Pediatric Neurol. 2012; 19(3): 107- 114. doi: 10.1016/j.spen.2012.02.003 22889539 · DOI
  92. [100]Venkatesan A Murphy OC. Viral encephalitis. Neurolo Clin. 2018; 36(4): 705- 724. doi: 10.1016/j.ncl.2018.07.001 30366550 · DOI
  93. [101]Patterson MC. Neurological complications of measles (rubeola). Curr Opin Neurol. 2020; 20(2): 2. doi: 10.1007/s11910-020-1023-y 32034528 · DOI

Cited by

Sorted by citations

Authors
Krett, J. D., Beckham, J. D., Tyler, K. L., Piquet, A. L., Chauhan, L., Wallace, C. J., Pastula, D. M., & Kapadia, R. K.
Affiliations
  • University of Calgary (CA)
  • University of Colorado Anschutz (US)
  • Colorado School of Public Health (US)
Corresponding author
Kapadia, Ronak K
ORCID
Venue
The Neurohospitalist
Publisher
SAGE Publications
Published
2022-05-27
Volume
12
Issue
4
Pages
632-646
ISSN
  • 1941-8744 (ISSN-L)
  • 1941-8752
DOI
10.1177/19418744221104778
PMC
PMC9485684
OpenAlex
W4281659487
Cited by
13
References
5
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 2
FWCI
0.35
Type
journal article
Language
en
Open access
Licence
Locations
  • The Neurohospitalist (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
Keywords
acute viral infection, human herpesviruses, arboviruses, enterovirus, neurological diagnosis, neurological treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review